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Reduced nicotinamide adenine dinucleotide (NADH):ubiquinone oxidoreductase (complex I) is the largest complex
of the mitochondrial respiratory chain and complex I deficiency accounts for ∼30% cases of respiratory-chain
deficiency in humans. Only seven mitochondrial DNA genes, but 135 nuclear genes encode complex I subunits. In
an attempt to elucidate the molecular bases of complex I deficiency, we studied the six most-conserved complex I
nuclear genes (NDUFV1, NDUFS8, NDUFS7, NDUFS1, NDUFA8, and NDUFB6) in a series of 36 patients with
isolated complex I deficiency by denaturing high-performance liquid chromatography and by direct sequencing of
the corresponding cDNA from cultured skin fibroblasts. In 3/36 patients, we identified, for the first time, five point
mutations (del222, D252G, M707V, R241W, and R557X) and one large-scale deletion in the NDUFS1 gene. In
addition, we found six novel NDUFV1 mutations (Y204C, C206G, E214K, IVS 8+41, A432P, and del nt 989–990)
in three other patients. The six unrelated patients presented with hypotonia, ataxia, psychomotor retardation, or
Leigh syndrome. These results suggest that screening for complex I nuclear gene mutations is of particular interest
in patients with complex I deficiency, even when normal respiratory-chain–enzyme activities in cultured fibroblasts
are observed.
Introduction
Reduced nicotinamide adenine dinucleotide (NADH):
ubiquinone oxidoreductase (complex I) catalyzes elec-
tron transfer from NADH to ubiquinone. This enzyme,
the largest complex of the mitochondrial respiratory
chain, contains 40 subunits (Fearnley and Walker
1992). It is embedded in the inner mitochondrial mem-
brane and is partly protruding in the matrix. Complex
I can be divided into three parts—namely, (1) the fla-
voprotein fraction, containing the binding sites for
NADH, flavin mononucleotide (FMN), and iron-sulfur
(Fe-S) clusters, (2) the iron protein fraction with several
Fe-S clusters, and (3) the hydrophobic fraction, which
binds quinone, in the inner membrane. Complex I de-
ficiency is the most common cause of mitochondrial dis-
orders. It represents largely one-third of all cases of res-
piratory chain deficiency (von Kleist-Retzow et al. 1998;
Kirby et al. 1999) and is responsible for a variety of
clinical symptoms, ranging from neurological disorders
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to cardiomyopathy, liver failure, and myopathy (von
Kleist-Retzow et al. 1998; Loeffen et al. 2000).
Most of the 43 complex I subunits are encoded by
nuclear genes, and only seven of them are mitochon-
drially encoded. Recently, mutations in nuclear complex
I genes have been identified in patients with Leigh syn-
drome. The disease-causing genes (NDUFS8 [MIM
602141], NDUFS4 [MIM 602694], NDUFS7 [MIM
601825], and NDUFV1 [MIM 161015]) (Loeffen et al.
2000) are highly conserved across species and play a
major role in catalytic activity (Fearnley and Walker
1992). In an attempt to identify the molecular bases of
the disease in our patients with complex I deficiency
and to contribute to genetic counseling, we developed
a systematic search for mutations in the six most-con-
served complex I nuclear genes by denaturating high-
performance liquid chromatography (D-HPLC) and di-
rect sequencing of their respective cDNA from cultured
skin fibroblasts of the probands. In this article, we
report on novel NDUFV1 and NDUFS1 mutations in
6/36 patients, thus supporting the high prevalence of
catalytic subunit gene mutations in complex I deficiency.
Patients
Family 1
A boy, whose parents were healthy, unrelated, and of
French origin, was born after a normal pregnancy and
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Table 1
Respiratory-Chain Analysis in Skeletal Muscle Mitochondria and Homogenates in Patients and Control
SOURCE, ACTIVITY, AND ACTIVITY RATIO
PATIENT FROM
80 CONTROLSFamily 3 Family 5 Family 6
Activity
(nmol/min/mg protein)
Muscle mitochondria:
NADH quinone reductase 15 106 29 47–182
Succinate quinone dichlorophenol indophenol reductase 116 164 77 69–268
Decylubiquinone cytochrome c reductase 900 … 510 421–1,654
Cytochrome c oxidase 833 1376 578 575–2,419
Pyruvate oxidase … 10 11 32–56
Malate oxidase 9 11 … 20–44
Succinate oxidase 35 40 46 34–92
Activity Ratio
Cytochrome c oxidase/NADH quinone reductase 55.5 13 19.9 9.91.6
Cytochrome c oxidase/succinate quinone dichlorophenol indophenol reductase 7.2 8.4 7.5 8.81.5
Cytochrome c oxidase/decylubiquinone cytochrome c reductase .9 … 1.1 1.4.2
Succinate oxidase/pyruvate oxidase 4.2 4.0 4.2 1.9.2
Family 1 Family 2 Family 4 51 Controls
Activity
(nmol/min/mg protein)
Muscle homogenate:
NADH quinone reductase 14 13 11 8–32
Succinate quinone dichlorophenol indophenol reductase 55 48 34 18–70
Decylubiquinone cytochrome c reductase 259 357 203 67–268
Cytochrome c oxidase 274 227 167 86–342
Activity Ratio
Cytochrome c oxidase/NADH quinone reductase 19.5 17.5 15.2 9.9.9
Cytochrome c oxidase/succinate quinone dichlorophenol indophenol reductase 5.0 4.7 5.0 5.4.4
Cytochrome c oxidase/decylubiquinone cytochrome c reductase 1.1 .6 .8 1.2.2
NOTE.—Substrate oxidation was polarographically measured (Rustin et al. 1994). Abnormal values are in bold italic.
delivery (birth weight 3,560 g). He was first hospitalized
at age 1 year for seizures and moderately elevated levels
of plasma lactate (2.6 mM). He then presented with
cerebellar ataxia with persistent seizures and was given
valproate. At age 28 mo, psychomotor regression, stra-
bismus, and ptosis were noted. Magnetic resonance im-
aging (MRI) showed brain atrophy and multiple sym-
metric areas of hyperintensity in the brain stem. He died
at age 3 years, of an acute episode of metabolic acidosis.
Postmortem analysis of the brain confirmed the gray
matter degeneration with foci of necrosis in the brain
stem. A complex I deficiency was identified in muscle
(table 1) and liver. Oxidation of NADH-generating sub-
strates was normal in cultured skin fibroblasts.
Family 2
A girl, the second child of healthy nonconsanguineous
parents of French origin, was born after a normal preg-
nancy and delivery (birth weight 3,600 g, length 48.5
cm, and head circumference 33 cm). She was hospital-
ized at age 6 mo for vomiting and floppiness. Recurrent
episodes of vomiting, hypotonia, lethargy, and apnea at
age 18 mo led to an intubation. Metabolic acidosis (pH
7.24, plasma bicarbonate 16 mM) with high levels of
lactate were noted (4 mM) and MRI (T2 sequence) re-
vealed areas of hyperintensity in the basal ganglia. She
died at age 18 mo, of an acute episode of metabolic
acidosis (bicarbonate 14 mM). A complex I deficiency
was identified in muscle (table 1) and liver. Oxidation
of NADH-generating substrates was normal in cultured
skin fibroblasts.
Family 3
A boy, whose parents were healthy, unrelated, and of
French origin, was born after a term pregnancy (weight
2,600 g, length 45 cm, and head circumference 33 cm).
At age 5 mo he had ptosis and strabismus. At age 9 mo
he was hypotonic and unable to sit. Ataxia, bilateral
ptosis, and ophthalmoplegia were noted, and he rapidly
developed a metabolic acidosis with high levels of lactate
(4.7, mM). MRI showed areas of hyperintensityN ! 2.3
of the locus niger. A complex I deficiency was identified
Table 2
Oligonucleotides Used for D-HPLC and Sequence Analysis of Complex I Subunits
Primer
Designationa
Primer Sequences
5′r 3′
Annealing Temperature
(C)
Acetonitrile
Gradient
(% Buffer B)
Mobile-Phase
Temperature
(C)
NDUFV1
(AF053070):b
F1 Ex 1–4 ATCGCGCCAGTTCCTCAGCC
CTGCAGATTGGAGGCCTCATT
60 59–68 64
F2 Ex 4–7 CGCGCTGCCTATATCTACATC
CATGACGATCACCGCAGCTGT
60 52–72 63
F3 Ex 7–10 CTGGTGCAGGCACAGACAGG
GTGGGCAGCACTCGCTTTATT
60 58–67 65
NDUFV1
(AF053069):c
Int 4-F AGTTATAGGCTGACTCCTGGG 60 … …
Int 5-R TAGCCAGATCCCGGGTGTCA 60 … …
Ex 6-F GTGGCCAACGTGGAGACAGT 60 … …
Ex 6-R TACCTCCACGGCGGCAGATT 60 … …
Ex 7-F CTGGTGCAGGCACAGACAGG 60 … …
Ex 7-R CATGACGATCACCGCAGCTGT 60 … …
Int 7-F GCTGAGGCCCAGGCTTCTGT 60 … …
Int 8-R GGGCTGCAGGCCACGTGG 60 … …
Ex 9-F GACTGGATGAACAAGGTGAT 60 … …
Ex 10-R CCGAAAGTGGCGGATCAGAC 60 … …
Ex 10-R.2 GTGGGCAGCACTCGCTTTATTG 60 … …
NDUFS1
(NM005006):b
F1 Ex 1–7 TAGCACAACACCCTCCGCGG
AATCGGCTCCTATGATTTCCAAA
58 55–64 60
F2 Ex 6–10 AATCACCCATTGGACTGTCCT
GGCAAATCTGGTTTTATCAGA
62 58–67 59
F3 Ex 9–13 AGAACTGGAGAAGTGATGAGGA
TAAGTCATTATGCAGGGAGCTC
61 [5 mM MgCl2] 56–65 59
F4 Ex 12–15 GGCAGATGTTGTTCTTCTGGTT
TCCATCTGCTCCCAGGAGAAA
60 [2.5% DMSO] 59–68 59
F5 Ex 15–19 CTTGGCTATAAGCCTGGGGTG
AACTGGGATCCTAGTAGAAGCT
60 59–68 59
NDUFS1
(AC007383):d
Ex 2 CCTACAATAATATAATTCTTTG
TAAGGTCTAATATCCACGAATGC
56 … …
Ex 3 ATAATAAACTGTTAATCTGTTTTTCG
ATTTACTAATAATCAGTATAAAGGAAA
56 … …
Ex 4 ATAACAGCAGTGAAGTCAGGTTATT
AGTTTGCTGCAAGATTTAAAGTTTT
60 … …
Ex 5 TTGTAATCACAAATAAATACAAATACA
TAAATTCTTAATCTATGGGAAGGTC
56 … …
Ex 6–7 GTCAGTGTGTGTGTATTTGAGAG
ATTGTGACTATTAAGTATACAATTATA
60 … …
Ex 8 GGACTTGACCATTGATGACAC
TTGAATAGTAATGAATTAAGGACAA
60 … …
Ex 9 AGCAACCATAGTAAACACCGTAT
ACTGTAAAAGTTAAGGAAAACAATA
60 … …
Ex 10 TATAGTTACTTCTTTAGCAAGATTC
CTTGATAATCACAAACACTATTTAAC
60 … …
Ex 11 TGCTGCGTGTAGGTTTCTTGG
ACATTTTATACATAACTTGTAACTAA
60 … …
Ex 12 ATGGATTCTCTGTATGTCTTAATT
CACTACCACTAACACTATTAGGA
60 … …
Ex 13 GTAAATAGATGTATCACTTAGGAT
TCAACAAGAGTAGATACACATAAG
62 … …
(continued)
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Table 2 (continued)
Primer
Designationa
Primer Sequences
5′r 3′
Annealing Temperature
(C)
Acetonitrile
Gradient
(% Buffer B)
Mobile-Phase
Temperature
(C)
Ex 14 ATATGGTTTGGTGTTCAGCTTAC
ACATATACACAACATTACTTGAATT
62 … …
Ex 15 ACATTGAAAATACTGCAGTTATGG
CTAACATACATAATGTACTACTCTC
60 … …
Ex 16 GATATATACTATCTTCATGTACAGTAGA
GGCTAAAATATCAAATATGCCTTTA
60 … …
Ex 17–18 TGTTGTTTTTGGGGACCTGACA
CTTACCTTTCGTATTTGGCAGAG
60 … …
Ex 19 AGTTGTATTATCAAAATGACATTTTC
AACTGGGATCCTAGTAGAAGCT
60 … …
NDUFS8
(U65579)c
TGGCCGAATGGCAGCGTCCT
CGATGTCATAGCGGGTGGTCC
64 56–65 67
CATTGCCTGCAAGCTCTGCG
TTTTATTGGGCAGCAGGGGCT
66 59–68 65
NDUFS7
(AC005329):c
CTGAAGGCCGAGGCCAAG
GTTGACGAGGTCATCCAG
60 52–61 68
AGAGCCGTGGCTCCCAAACC
ATGTCCACGGGCACGATGCG
60 54–63 67
CTATTCCTACTCGGTGGT
CCTCACGGGACACAAGCA
60 51–60 68
NDUFA8
(NM014222):c
GGGAGTTCAAGGAGACGGGGG
CAATGCAAGTCCAATATTCTG
60 54–63 62
TTAGGCAGATAAAACGTCACT
CTGAGCACATGACCGAGTGTGG
60 55–64 62
NDUFB6
(NM002493):c
GGTGCGCCGTGTCCTTTT
TGGTAATATAGGAACAAACTT
60 57–66 57
a GenBank accession numbers are indicated.
b cDNA sequence analysis.
c Genomic sequence analysis, performed by means of nested primers.
d Genomic sequence analysis.
in muscle (table 1). Oxidation of NADH-generating sub-
strates was normal in both cultured skin fibroblasts and
circulating lymphocytes.
Family 4
The fourth-born child of unrelated healthy parents
was normal until age 4 mo, when he developed psycho-
motor retardation with hypotonia. At age 7 mo, he
presented nystagmus and bilateral optic atrophy. Leu-
kodystrophy, lactic acidosis (4.4 mM), and hyperlacta-
torachia were also noted (3.2 mM). He died at age 10
mo, from an acute episode of bradycardia. His older
sister also presented with hyperlactatemia, hypotonia,
pyramidal syndrome, and leukodystrophy; she died at
age 7 mo. His older brother developed two episodes of
ataxia and mild psychomotor retardation at age 2 years.
A complex I deficiency was identified in muscle (table
1) and liver. Decreased NADH-generating substrates ox-
idation in fibroblasts suggested a complex I deficiency.
Lymphocytes were normal.
Family 5
The fourth child (weight 3,100 g, height 49 cm, and
head circumference 34 cm) of unrelated healthy parents
was normal until age 2 mo, when he presented with
growth retardation, axial hypotonia, hepatomegaly, and
persistent hyperlactatemia (5 mM). An MRI showed hy-
perintensity of basal ganglia. The child then developed
macrocytic anemia and dystonia. He died suddenly, at
age 5 mo. His older sister presented with growth retar-
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dation, macrocytic anemia, and metabolic acidosis, at
age 3 mo. Shortly thereafter she died, after an acute
episode of hyperlactatemia. Oxidation of NADH-gen-
erating substrates was low in muscle mitochondria (table
1), in fibroblasts, and in circulating lymphocytes.
Family 6
The third boy (weight 2,900 g, height 48.5 cm, and
head circumference 37 cm) of unrelated healthy Portu-
guese parents presented, shortly after birth, with failure
to thrive with hypotonia, microcephalia, and pyramidal
syndrome. At age 5 mo, he developed hyperlactatemia
(5.3 mM) and hyperlactatorachia (4 mM). An MRI
showed structural abnormalities of the corona radiata,
suggestive of Leigh syndrome, and permanent anemia
necessitated blood transfusions. A complex I deficiency
was identified in muscle (table 1). Cultured skin fibro-
blasts normally oxidized NADH-generating substrates.
Methods
Polarographic tests and/or spectrophotometric assays of
respiratory-chain enzymes were performed on skeletal
muscle mitochondria, muscle homogenate, liver homog-
enate, cultured skin fibroblasts, or circulating lympho-
cytes, as described elsewhere (Rustin et al. 1994). Total
RNAs were extracted from cultured skin fibroblasts, by
means of the Rnasin kit (Qiagen), and were reverse tran-
scribed with random hexamer primers (GenAmp RNA
PCR core kit, Applied Biosystems). The reverse tran-
scriptase (RT)–PCR amplification of specific RNA was
performed in overlapping fragments spanning the en-
tire coding region of the NDUFV1 (MIM 161015),
NDUFS8 (MIM 602141), NDUFS7 (MIM 601825),
NDUFS1 (MIM 157655), NDUFA8 (MIM 603359),
and NDUFB6 (MIM 603322) genes. Table 2 shows the
sequence of primers as well as PCR and D-HPLC con-
ditions. Amplification products were mixed with control
PCR products. This mixture was denatured for 10 min
at 96C and then gradually reannealed by decreasing
sample temperature from 96C to 30C. The annealed
specimens (4–7 ml) were loaded onto a DNA sep column
(Transgenomic) by means of a Dynamax automatic sam-
ple injector model AI-1A. PCR products were then sep-
arated over a 4.5-min period through a linear acetonitrile
gradient (flow rate: 0.9 ml/min), the values of which
were based on the size and G/C content of the PCR
products (table 2). The column mobile phase consisted
of a mixture of 0.1 M triethylamine acetate (TEEA), pH
7.0 with (buffer A) or without 25% acetonitrile (buffer
B). The mobile-phase temperatures required for optimal
resolution of homoduplexes were empirically deter-
mined by injecting the product of each amplified frag-
ment at increasing temperatures until a significant
decrease in sample retention time was observed. The
temperatures resulting in 75% of double-strand DNA
in the melting profile curve were considered as the op-
timal ones. Specific values for the gradient ranges and
mobile-phase temperatures used are reported in table 2.
PCR fragments displaying abnormal profiles were fur-
ther characterized by direct sequencing using the BigDye
terminator cycle sequencing kit (ABI Prism).
For genotyping, microsatellite markers of the Ge´ne´-
thon database were used (Dib et al. 1996). PCR prod-
ucts were loaded on a polyacrylamide gel and trans-
ferred onto a positive nylon membrane (Nytran plus,
Schleicher and Schuell). Membranes were hybridized
with a (CA)12 probe. The labeling of the probe and the
revelation of the blots were performed by means of the
ECLTM direct nucleic acid labeling and detection system
(Amersham Pharmacia Biotech). The blots were auto-
radiographed with Kodak-X-OMAT films for 2–30
min.
Results
NDUFV1 Gene Mutations
The entire coding sequence of theNDUFV1,NDUFS8,
NDUFS7, NDUFS1, NDUFA8, andNDUFB6 genes was
submitted to D-HPLC analysis in 36 unrelated complex
I–deficient patients. Abnormal D-HPLC patterns in the
NDUFV1 gene (i.e., additional peaks caused by the re-
duced retention time of heteroduplex DNAs) were found
in 3/36 patients (fig. 1). In patient 1, a seemingly ho-
mozygous GrA transition at nucleotide (nt) 640 in exon
5 changed a highly conserved glutamic acid into a lysine
(E214K inherited from the father, fig. 2, nt 1 is the “A”
of the ATG translation initiation codon). Since the par-
ents were unrelated, we sequenced the NDUFV1 ge-
nomic DNA of the patient and found that he was in fact
compound heterozygous for the E214K mutation and
had an ArC transversion in the donor splice-site of
intron 8, inherited from the mother (fig. 2), resulting in
the skipping of exon 8 and in an unstable RNA (not
shown). In patient 2, a seemingly homozygous GrC
substitution in exon 9 at nt 1294 of the cDNA changed
a highly conserved alanine into a proline (A432P, fig.
2). Again, the patient was in fact compound heterozy-
gous for the A432P mutation inherited from the father
and a 2-bp deletion in exon 7 inherited from the mother,
resulting in a frameshift and a premature stop codon
(fig. 2). This mRNA was unstable, as it was almost un-
detectable at the cDNA level (not shown). In patient 3,
sequencing the abnormal PCR fragment detected com-
pound heterozygosity for two exon 5 mutations. An
ArG transition at nt 611 inherited from the father
changed a tyrosine into a cysteine in the NDUFV1 pro-
tein (Y204C; fig. 2). The second mutation, a TrG trans-
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Figure 1 Abnormal D-HPLC patterns of NDUFV1 and
NDUFS1 RT-PCR products. “F2,” “F3,” and “F5” refer to the dif-
ferent PCR fragments (table 2). C p control; 1–5 p patients 1–5.
Figure 2 Molecular analysis of the NDUFV1 gene. Sequence
analysis was performed on genomic DNA for patients 1 and 2, and
on cDNA derived from skin fibroblast for patient 3. Sequence align-
ment of the NDUFV1 proteins from various species is presented. Boxes
indicate the FMN binding site. Arrows show the mutated amino acids
(patient 1: E214K; patient 2: A432P; patient 3: Y204C and C206G).
version at nt 616, inherited from the mother, changed a
cysteine into a glycine (C206G; fig. 2). None of the mis-
sense mutations identified in the patients were found in
100 controls.
Interestingly, all three NDUFV1 mutations (Y204C,
C206G, and E214K) altered the FMN binding site of
the NDUFV1 protein (Fearnley and Walker 1992) (fig.
2). Yet, the patients failed to express complex I deficiency
in their cultured skin fibroblasts, since pyruvate-malate
and glutamate-malate oxidations were in the normal
range (not shown). We hypothesized that the high con-
centration of riboflavin (the FMN precursor) in the cul-
ture medium might have restored normal complex I
activity, and we grew the patients’ skin fibroblasts in
Rosswell Park Memorial Institute riboflavin-free me-
dium supplemented with 10% fetal-calf serum. How-
ever, we failed to reveal an enzyme deficiency in cultured
cells in these conditions (not shown), presumably caused
by the presence of traces of riboflavin in the serum, but
we still decided to put patient 3, the only patient alive,
on a riboflavin treatment (60 mg/day). At age 10 mo,
his severe ptosis had improved on a low-carbohydrate
diet. At age 2 years, he received oral idebenone for 7
mo, followed by a 3-mo riboflavin treatment, which re-
sulted in the disappearance of his ptosis and ophthal-
moplegia and the recovery of a normal growth. How-
ever, ataxia and pyramidal syndrome persisted. The boy
is now 3 years of age; he is unable to walk unaided and
is still mentally retarded.
NDUFS1 Gene Mutations
Abnormal D-HPLC patterns in the NDUFS1 gene
were found in 3/36 patients (fig. 1). Sequencing the ab-
normal PCR fragments revealed that patient 4 was com-
pound heterozygous for a 3-bp deletion in exon 8 at nt
664–666, resulting in an in-frame codon 222 deletion
(fig. 3) and an ArG substitution at nt 755 in exon 9,
changing a highly conserved asparagine into a glycine
in the protein (D252G; fig. 2). In patient 5, a seemingly
homozygous CrT transition at nt 721 of the cDNA
changed a highly conserved arginine into a tryptophan
(R241W; fig. 3). We determined the exon-intron bound-
aries of the gene by combining BLAST searching with
the cDNA sequence and PCR-sequence analysis, which
allowedus to identify a genomic clone containing the
entire NDUFS1 coding sequence. Primers used for exon
amplification on genomic DNA are presented in table 2.
The patient was, in fact, compound heterozygous for the
R241W and a R557X mutation (inherited, respectively,
from the father and the mother) detected on genomic
DNA (fig. 3). In patient 6, an apparently homozygote
ArG transition at nt 2119 in exon 19 changed a highly
conserved methionine into a valine (M707V; fig. 3). His
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Figure 3 Molecular analysis of the NDUFS1 gene. Sequence
analysis was performed on cDNA for patient 4 and on genomic DNA
for patients 5 and 6. Sequence alignment of the NDUFS1 proteins
from various species is presented. Arrows show the mutated amino
acids (patient 4: D252G and del 222; patient 5: R241W; patient 6:
M707V).
Figure 4 Haplotype analysis of family 6. Haplotypes are given
(top to bottom) for loci D2S113, D2S368, D2S156, D2S138, D2S389,
D2S311, D2S369, D2S155, D3S164, D2S159, and D2S125. The box
indicates the deleted region between 2q32.1 and q34.
mother was heterozygous for the M707V mutation. Sur-
prisingly however, his father was wild-type homozygous.
Segregation analysis of microsatellite markers flanking
the NDUFS1 gene on chromosome 2q revealed that pa-
tient 6 failed to inherit polymorphic markers from his
father at loci D2S138–D2S155 (44 cM), providing ev-
idence of a de novo deletion of the paternal NDUFS1
allele (fig. 4).
No mutations could be identified in the NDUFS8,
NDUFS7, NDUFA8, and NDUFB6 genes. In several
patients, neutral polymorphisms were detected either in
the coding or in the noncoding regions of the genes (not
shown).
Discussion
In this article, we report on a large-scale NDUFS1
deletion and 11 novel mutations in the NDUFV1 and
NDUFS1 genes of complex I in 6/36 unrelated complex
I–deficient children. All the mutations reported in this
study involved highly conserved amino acids, and three
of them altered the FMN binding site of NDUFV1, pos-
sibly hampering FMN binding to complex I and reduc-
ing electron transfer through the respiratory chain. Non-
sense mutations have been reported elsewhere in the
NDUFV1, NDUFS8, NDUFS7, and NDUFS4 genes
(Schuelke et al. 1999; Smeitink et al. 1999; Loeffen et
al. 2000). To our knowledge, however, neitherNDUFS1
mutations nor nuclear DNA deletion have been reported
in respiratory-chain deficiency. This study not only dem-
onstrates the autosomal recessive mode of inheritance
of the disease in most patients but also suggests that de
novo deletions can be occasionally involved. The direct
measurement of complex I in cultured skin fibroblasts
is hampered by a contaminating microsomal NADH cy-
tochrome c reductase activity. This feature prevents the
reliable quantitation of complex I deficiency in cultured
fibroblasts. For this reason, only polarographic assays
of pyruvate or malate oxidation were performed to es-
timate the activity of NADH oxidation by complex I,
and only fibroblasts showing severely decreased pyru-
vate or malate oxidation can be reliably considered as
complex I deficient. As enzymological diagnosis of com-
plex I deficiency in chorionic villi or amniotic fluid is
hazardous, the identification of the mutant genotypes
allowed us to offer prenatal diagnosis for the next preg-
nancies (Amiel et al., in press). In mutations altering the
FMN binding site, the presence of the FMN precursor
(riboflavin) in the culture medium might have restored
a normal complex I activity.
Several of the complex I 43 subunits are highly con-
served across species, from mammals to bacteria (Fearn-
ley and Walker 1992). This high degree of conservation
suggests that these subunits play a key role in catalytic
activity, especially as they encompass the NADH, FMN,
or Fe-S binding sites. The most conserved subunits and
those of functional importance for electron transfer and
substrate oxidation represent, therefore, obvious can-
didates for other cases of complex I deficiency, but the
large number of genes possibly underlying complex I
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deficiency requires rapid mutation-screening techniques
such as D-HPLC or microarrays. Until now, complex I
deficiency has only been ascribed to nuclear genes en-
coding structural complex I subunits. However, it is con-
ceivable that complex I deficiency might result from an
abnormal complex I subunit assembly, as observed in
complex IV deficiency (Tiranti et al. 1998; Zhu et al.
1998; Valnot et al. 2000a, 2000b). Until now, only two
Neurospora crassa genes encoding chaperones have
been shown to govern assembly of complex I (Kuffner
et al. 1998). The human homologues of these genes will
represent obvious candidate genes for complex I
deficiency.
Although complex I subunit genes are ubiquitously
expressed, the patients reported in this study presented
mostly neurological disorders—namely, hypotonia,
ataxia, psychomotor retardation, or Leigh syndrome. It
has been claimed that the variable clinical expression
of mitochondrial disorders could be ascribed to mito-
chondrial DNA mutations, the expression of the de-
ficiency paralleling the level of heteroplasmy in the
corresponding tissue (Munnich et al. 2001). Yet, an
increasing number of ubiquitously expressed nuclear
genes have been shown to account for mitochondrial
disorders affecting specific organs. Indeed, thymidine
phosphorylase, SURF1, SCO1, SCO2, COX10, fra-
taxin, DDP, OPA1, and ABC7, which are all house-
keeping genes, are involved in MNGIE (Nishino et al.
1999), Leigh syndrome (Tiranti et al. 1998; Zhu et al.
1998), hepatic failure (Valnot et al. 2000a, 2000b), car-
dioencephalomyopathy (Papadopoulou et al. 1999),
tubulopathy (Valnot et al. 2000a, 2000b), Friedreich
ataxia (Campuzano et al. 1996), deafness-dystonia syn-
drome (Koehler et al. 1999), optic atrophy (Delettre et
al. 2000), and sideroblastic anemia-ataxia (Allikmets et
al. 1999). This suggests that other as yet unknown
mechanisms play an important role in the variable clin-
ical expression of the disease. Noticeably, neither our
patients nor those reported elsewhere presented Leber
hereditary optic atrophy (LHON), whereas mitochon-
drial complex I gene mutations most often result in
LHON (MITOMAP). The identification of other genes
responsible for complex I deficiency will, it is hoped,
help in the elucidation of the variable clinical expression
of complex I deficiency. Still, the increasing number of
disease genes will require fast and cost-effective muta-
tion screening techniques for rapid identification of dis-
ease-causing mutations, genetic counseling, and pre-
natal diagnosis.
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